SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-13-000325
Filing Date
2013-08-12
Accepted
2013-08-12 17:27:38
Documents
5
Period of Report
2013-05-29
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A hptx-8k_20130812.htm 8-K/A 62409
2 EX-23.1 hptx-ex23_201308116.htm EX-23 4787
3 EX-23.2 hptx-ex23_201308117.htm EX-23 3709
4 EX-99.1 hptx-ex991_2013081110.htm EX-99 346889
5 EX-99.1 hptx-ex992_201308119.htm EX-99 539394
  Complete submission text file 0001564590-13-000325.txt   958282
Mailing Address 601 GATEWAY BLVD. SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BLVD. SUITE 200 SOUTH SAN FRANCISCO CA 94080 650-745-7802
HYPERION THERAPEUTICS INC (Filer) CIK: 0001386858 (see all company filings)

IRS No.: 611512713 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35614 | Film No.: 131030643
SIC: 2834 Pharmaceutical Preparations